According to Intercept Pharmaceuticals 's latest financial reports the company's current earnings are S$0.31 Billion. In 2022 the company made an earning of -S$0.22 Billion a decrease over its 2021 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -S$77.53 Million | -63.6% |
2022 | -S$0.22 Billion | 74.17% |
2021 | -S$0.13 Billion | -66.74% |
2020 | -S$0.37 Billion | -20.25% |
2019 | -S$0.47 Billion | 11.46% |
2018 | -S$0.42 Billion | -14.19% |
2017 | -S$0.49 Billion | -12.71% |
2016 | -S$0.56 Billion | 82.32% |
2015 | -S$0.31 Billion | -23.21% |
2014 | -S$0.4 Billion | 334.95% |
2013 | -S$90.67 Million | 60.48% |
2012 | -S$56.5 Million |